You are viewing the site in preview mode

Skip to main content

Table 1 Mean (+/- SD) serum lipids and e-GFR.

From: The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients

   TC mmol/l TG mmol/l HDL mmol/l TC/HDL e-GFR ml/min
Truvada Baseline 4.0 (0.9) 1.3 (0.8) 1.2 (0.4) 3.6 (1.9) 104.7 (24.0)
  48 weeks 4.2 (0.9) 1.3 (0.9) 1.5 (0.5) 3.3 (1.1) 108.3 (36.5)
Kivexa Baseline 4.4 (0.8) 1.5 (1.0) 1.1 (0.3) 3.8 (1.1) 104.8 (30.0)
  48 weeks 5.0 (1.0) 1.5 (1.0) 1.7 (0.8) 3.3 (1.2) 117.3 (31.7)
p-values   0.04 0.7 0.7 0.3 0.1